Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Eyes and Vision

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Intravitreal dexamethasone implant 0.7 mg vs antiVEGF

Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes

Intravitreal dexamethasone implant 0.7 mg probably leads to higher use of IOP‐lowering medications ‐ 24 months compared with intravitreal antiVEGF (moderate certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 4.76 [2.84, 7.99]
Studies not reported
Moderate

Intravitreal dexamethasone implant 0.7 mg vs sham

Use of IOP‐lowering medications · macular edema in diabetes

Intravitreal dexamethasone implant 0.7 mg probably leads to higher use of IOP‐lowering medications ‐ 36 months compared with sham (moderate certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 4.54 [3.19, 6.46]
1 study · 697 participants
Moderate